Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
In Vitro Activity Assay from US Patent US11944616: "Dizocilpine derivatives as peripheral NMDA receptor antagonists"
Assay data:10 Active, 9 Activity ≤ 1 µM, 10 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Glutamate, NMDA, Glycine Eurofins Panlabs panel
Glutamate, NMDA, Agonism Eurofins Panlabs panel
Glutamate, Kainate Eurofins Panlabs panel
Glutamate, AMPA Eurofins Panlabs panel
NMDA/R Eurofins SafetyScreen44 (BI)
Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration
Assay data:10 Active, 4 Activity ≤ 1 µM, 1125 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Antagonist activity at NMDA receptor (unknown origin) assessed as inhibition constant
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of GluN1/GluN2B NMDA receptor (unknown origin) expressed in HEK293 cells
Assay data:2 Active, 1 Activity ≤ 1 µM, 5 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on